While our study reveals the regulation of the EZH2 chromatin modifying enzyme by NFIB is a key conduit of this effect in melanoma cells, it remains to be determined if a similar epigenetic axis is governed via an NFIB-EZH2 axis in other tumour types to drive invasion and metastasis. This evidence concerns the gene EZH2 and neoplasm.